An Update on Candida tropicalis Based on Basic and Clinical Approaches

Area of Science:

• Medical Mycology
• Microbial Pathogenesis
• Biotechnology

Background:

• Candida tropicalis is a leading cause of candidemia, particularly in Asia and Latin America.
• It exhibits high virulence, second only to Candida albicans, and is a strong biofilm producer.
• This species possesses multiple virulence factors, including enzyme secretion and morphogenesis.

Purpose of the Study:

• To provide an updated overview of Candida tropicalis.
• To highlight its clinical relevance, virulence, and biotechnological potential.
• To discuss antifungal resistance and osmotolerance.

Main Methods:

• Review of existing literature on Candida tropicalis.
• Analysis of virulence factors, biofilm production, and antifungal resistance.
• Examination of osmotolerance and biotechnological applications.

Main Results:

• Candida tropicalis is a major opportunistic pathogen with significant virulence and biofilm-forming capabilities.
• Antifungal resistance to common treatments like azoles, polyenes, and echinocandins is documented.
• Its osmotolerance is a key characteristic for survival in saline environments and for biotechnological use.

Conclusions:

• Candida tropicalis is a clinically important yeast with diverse virulence factors and emerging antifungal resistance.
• Its osmotolerance presents unique opportunities for biotechnological applications.
• Further research is warranted to understand and combat this resilient pathogen.